Recent Updates
Recently added Catalysts
CGEM Positive Sentiment Score: 60/100

Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Thursday, January 30, 2025 1 min read
Key Takeaway: Cullinan Therapeutics, Inc. announced that CEO Nadim Ahmed and CMO Jeffrey Jones will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference. The conference is slated to occur in New York on February 5 and 6, 2025. The discussion will be accessible via a webcast on the company's investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cullinan Therapeutics will be visible to investors at a major conference.
  • Participation in the fireside chat showcases company leadership.
  • The event presents opportunities for networking and collaboration.

Full Press Release Details

CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference, being held in New York on February 5 and 6, 2025.
The fireside chat is scheduled for Wednesday, February 5, 2025, at 9:30 a.m. ET. A webcast of the fireside chat will be available under the Events and Presentations section of the Company’s investor relations website at https://cullinantherapeutics.com/events-and-presentations/.
About Cullinan Therapeutics
nsmith@cullinantx.com
rweldon@cullinantx.com

Frequently Asked Questions

When will Cullinan Therapeutics' fireside chat take place?

The fireside chat is on February 5, 2025, at 9:30 a.m. ET.

Who will participate in the fireside chat?

Nadim Ahmed and Jeffrey Jones, M.D., M.B.A., will participate.

Where can I watch the webcast of the chat?

The webcast will be available on the Company's investor relations website.

What is Cullinan Therapeutics focused on?

Cullinan Therapeutics develops modality-agnostic targeted therapies.

What conference will Cullinan Therapeutics attend?

They will participate in the Guggenheim Securities SMID Cap Biotech Conference.

Tags: CGEM Viatris Investor Conferences Healthcare biotech conference Guggenheim Securities Nadim Ahmed biopharmaceuticals
Last updated: Jan 30, 2025